Using an explicit guideline-based criterion and implicit review to assess antipsychotic dosing performance for schizophrenia

International Journal for Quality in Health Care

Volumn 14, Issue 3, 2002, Pages 199-206

  Owen, Richard R ^a,b   Thrush, Carol R ^a,b   Hudson, Teresa J ^a,b   Mallory, Susan R ^c   Fischer, Ellen P ^a,b   Clardy, James A ^b   Williams, D Keith ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Valley Mental Health   (United States)

Author keywords

Antipsychotic agents; Guidelines; Quality indicators; Schizophrenia; Sensitivity and specificity

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRIST; QUALITY CONTROL; RATING SCALE; RISK ASSESSMENT; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0036083206     PISSN: 13534505     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.intqhc.a002611     Document Type: Article

References (45)

1. Evaluating the quality of medical care
2. Quality-of-care assessment: Choosing a method for peer review
3. The quest to quantify quality
4. A method of developing and weighting explicit process of care criteria for quality assessment
5. An empirical assessment of the validity of explicit and implicit process-of-care criteria for quality assessment
6. Rolling down the runway: The challenges ahead for quality report cards
7. Performance measurement: Problems and solution
8. Practice guideline for the treatment of patients with schizophrenia
9. Treatment of schizophrenia
10. Co-Investigators of the PORT Project. At issue: Translating research into practice: The schizophrenia patient outcomes research team (PORT) treatment recommendations
11. Veterans Health Administration Clinical Guideline for Management of Persons With Psychoses
12. Survey Co-Investigators of the PORT Project. Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey
13. Antipsychotic drug doses in a schizophrenia inpatient unit
14. Using a computer database to monitor compliance with pharmacotherapeutic guidelines for schizophrenia
15. Patients with schizophrenia at risk for excessive antipsychotic dosing
16. Performance measurement for schizophrenia: Adherence to guideline recommendations for antipsychotic dose
17. The feasibility of using automated data to assess guideline-concordant care for schizophrenia
18. Validating quality indicators for hospital care
19. Choosing and evaluating clinical performance measures
20. The reliability of peer assessments of quality of care
21. Peer review of the quality of care: Reliability and sources of variability for outcome and process assessments
22. Using administrative databases to evaluate the quality of medical care: A conceptual framework
23. Designing and testing medical review criteria and performance measures
24. Substance abuse, community service use, and symptom severity of urban and rural residents with schizophrenia
25. An instrument for measurement of outcomes of care for schizophrenia: Issues in development and implementation
26. User's Guide for the Structured Clinical Interview for DSM-III-R
27. Predicting the appropriate use of carotid endarterectomy, upper gastrointestinal endoscopy, and coronary angiography
28. Effect of outcome on physician judgments of appropriateness of care
29. Guidelines for Structured Implicit Review of The Quality of Hospital Care for Diverse Medical and Surgical Conditions
30. Changes in quality of care for five diseases measured by implicit review, 1981 to 1986
31. Evaluating the care of general medicine inpatients: How good is implicit review?
32. High agreement but low kappa: I. The problems of two paradoxes
33. High agreement but low kappa: II. Resolving the paradoxes
34. Dissimilar dosing with high-potency and low-potency neuroleptics
35. Psychopharmacological screening criteria
36. Measuring the quality of outpatient treatment for schizophrenia
37. Benchmarking treatment of schizophrenia: A comparison of service delivery by the national government and by state and local providers
38. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: Individual and facility predictors
39. Use of administrative data to find substandard care: Validation of the complications screening program
40. Measuring antidepressant prescribing practice in a health care system using administrative data: Implications for quality measurement and improvement
41. Depot neuroleptics: A comparative review of standard, intermediate, and low-dose regimens
42. Quality measures for mental health care: Results from a national inventory
43. Quality-of-care research in mental health: Responding to the challenge